You are on page 1of 2

Note: This letter references Pfizer’s “Global Update”

for Depo-Medrol® on 6/25/13. The request was
simultaneously submitted to every nation’s health
authority including the US-FDA in Washington DC.
This was confirmed by Pfizer NYC on 2/28/2014